Portola Pharma (PTLA) Reports Q3 Loss of $1.64/Share

November 7, 2016 4:35 PM EST
Get Alerts PTLA Hot Sheet
Trade PTLA Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Portola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($1.64), may not compare to the analyst estimate of ($1.10).

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment